Skip to content
10-Q

Quarterly Report

Flexion Therapeutics, Inc.

0000950170-21-004377

← back to feed
Filed
Nov 12, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 1, 2021 50.32M sh
Capex Q3 2021 · Sep 30, 2021 $1.74M
Capex Q3 2021 · Sep 30, 2020 $8.86M
Operating Cash Flow Q3 2021 · Sep 30, 2021 −$51.44M
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$60.82M
Long Term Debt Q3 2021 · Sep 30, 2021 $80.09M
Long Term Debt Q3 2021 · Dec 31, 2020 $44.11M
Short Term Debt Q3 2021 · Sep 30, 2021 $0
Short Term Debt Q3 2021 · Dec 31, 2020 $16.81M
Cash And Equivalents Q3 2021 · Sep 30, 2021 $136.82M
Cash And Equivalents Q3 2021 · Dec 31, 2020 $107.7M
Stockholders Equity Q3 2021 · Sep 30, 2021 −$82.38M
Stockholders Equity Q3 2021 · Jun 30, 2021 −$56.17M
Stockholders Equity Q3 2021 · Mar 31, 2021 −$38.87M
Stockholders Equity Q3 2021 · Dec 31, 2020 −$16.66M
Stockholders Equity Q3 2021 · Sep 30, 2020 −$3.1M
Stockholders Equity Q3 2021 · Jun 30, 2020 $16.52M
Stockholders Equity Q3 2021 · Mar 31, 2020 −$52.31M
Stockholders Equity Q3 2021 · Dec 31, 2019 −$20.11M
Current Liabilities Q3 2021 · Sep 30, 2021 $43.99M
Current Liabilities Q3 2021 · Dec 31, 2020 $55.27M
Total Liabilities Q3 2021 · Sep 30, 2021 $300.31M
Total Liabilities Q3 2021 · Dec 31, 2020 $268.59M
Current Assets Q3 2021 · Sep 30, 2021 $192.76M
Current Assets Q3 2021 · Dec 31, 2020 $225.81M
Total Assets Q3 2021 · Sep 30, 2021 $217.93M
Total Assets Q3 2021 · Dec 31, 2020 $251.93M
Sga Expense Q3 2021 · Sep 30, 2021 $26.99M
Sga Expense Q3 2021 · Sep 30, 2021 $81.99M
Sga Expense Q3 2021 · Sep 30, 2020 $27.31M
Sga Expense Q3 2021 · Sep 30, 2020 $81.34M
Rd Expense Q3 2021 · Sep 30, 2021 $14.77M
Rd Expense Q3 2021 · Sep 30, 2021 $41.49M
Rd Expense Q3 2021 · Sep 30, 2020 $10.09M
Rd Expense Q3 2021 · Sep 30, 2020 $43.73M
Net Income Q3 2021 · Sep 30, 2021 −$30.31M
Net Income Q3 2021 · Sep 30, 2021 −$81.08M
Net Income Q3 2021 · Jun 30, 2021 −$22.21M
Net Income Q3 2021 · Mar 31, 2021 −$28.56M
Net Income Q3 2021 · Sep 30, 2020 −$24.64M
Net Income Q3 2021 · Sep 30, 2020 −$94.06M
Net Income Q3 2021 · Jun 30, 2020 −$32.62M
Net Income Q3 2021 · Mar 31, 2020 −$36.8M
Operating Income Q3 2021 · Sep 30, 2021 −$24.16M
Operating Income Q3 2021 · Sep 30, 2021 −$64.18M
Operating Income Q3 2021 · Sep 30, 2020 −$18.87M
Operating Income Q3 2021 · Sep 30, 2020 −$78.72M
Cost Of Revenue Q3 2021 · Sep 30, 2021 $3.73M
Cost Of Revenue Q3 2021 · Sep 30, 2021 $14.79M
Cost Of Revenue Q3 2021 · Sep 30, 2020 $5.13M
Cost Of Revenue Q3 2021 · Sep 30, 2020 $12.89M
Revenue Q3 2021 · Sep 30, 2021 $21.33M
Revenue Q3 2021 · Sep 30, 2021 $74.09M
Revenue Q3 2021 · Sep 30, 2020 $23.66M
Revenue Q3 2021 · Sep 30, 2020 $59.24M